This study supports the importance of regulatory role of the E2 in growth hormone secretion in women with polycystic ovary syndrome, showing for the first time a different weight-related sensitivity of the growth-hormone axis to hypoestrogenism induced by gonadotropin-releasing hormone agonist. © by 2004 American Society for Reproductive Medicine.
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome
Guido M.;
2004-01-01
Abstract
This study supports the importance of regulatory role of the E2 in growth hormone secretion in women with polycystic ovary syndrome, showing for the first time a different weight-related sensitivity of the growth-hormone axis to hypoestrogenism induced by gonadotropin-releasing hormone agonist. © by 2004 American Society for Reproductive Medicine.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.